CD274 and gastric cancer: The fact that in gastric cancer, expression of programmed cell death ligands 1 and 2 (PD-L1/2) is elevated and there is a "high mutational load" could bode well for anti–PD-1/PD-L1 antibodies (Muro et al., 2016).